Livzon Pharmaceutical Group Inc.
31
2
2
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 31 trials
100.0%
+13.5% vs industry average
39%
12 trials in Phase 3/4
0%
0 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD
Role: collaborator
DBM-1152A Inhalation Solution in Chinese Healthy Subjects
Role: collaborator
DBM-1152A Inhalation Solution in Healthy Volunteers
Role: collaborator
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Role: lead
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
Role: lead
A Study to Evaluate the Efficacy and Safety of LZM012
Role: lead
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
Role: lead
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Role: lead
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Role: lead
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Role: lead
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
Role: lead
Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351
Role: lead
Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine
Role: lead
The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine
Role: lead
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Role: lead
The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers
Role: collaborator
Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization
Role: lead
LZM009 to Treat Patients With Advanced Solid Tumors
Role: lead
Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US
Role: lead
Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract .
Role: lead